You are here
Acenta Discovery, Inc.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of NET-Selective Piperidine-Based PET Ligand
Amount: $499,986.00DESCRIPTION (provided by applicant): World-wide public health surveys point to an increasing global health burden resulting from serious brain disorders, particularly mood-related disorders such as de ...
STTRPhase I2005Department of Health and Human Services National Institutes of Health -
Development of NET-Selective Piperidine-Based PET Ligand
Amount: $499,986.00DESCRIPTION (provided by applicant): World-wide public health surveys point to an increasing global health burden resulting from serious brain disorders, particularly mood-related disorders such as de ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
Akt Inhibitors to Treat Ewing's Sarcoma
Amount: $596,620.00DESCRIPTION (provided by applicant): Novel drugs that improve overall survival with decreased morbidity are critical in the war on cancer. Acenta Discovery Inc. has partnered with the Toretsky Lab o ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
Caspase Inhibitor for Neuroprotection
Amount: $348,523.00DESCRIPTION (provided by applicant): An important role for apoptosis has been established in various pathological processes, particularly in nervous tissues. Apoptosis essentially contributes to neuro ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
Akt Inhibitors to Treat Ewing's Sarcoma
Amount: $596,620.00DESCRIPTION (provided by applicant): Novel drugs that improve overall survival with decreased morbidity are critical in the war on cancer. Acenta Discovery Inc. has partnered with the Toretsky Lab o ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Caspase Inhibitor for Neuroprotection
Amount: $348,523.00DESCRIPTION (provided by applicant): An important role for apoptosis has been established in various pathological processes, particularly in nervous tissues. Apoptosis essentially contributes to neuro ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
NET- Selective Ligands for the Treatment of Depression
Amount: $545,039.00DESCRIPTION (provided by applicant): World-wide public health surveys point to an increased global health burden for serious psychiatric disorders, particularly depression. Indeed, by 2020 it is ex ...
STTRPhase I2003Department of Health and Human Services National Institutes of Health